141 related articles for article (PubMed ID: 38137802)
1. Complement and Non-Complement Binding Anti-HLA Antibodies Are Differentially Detected with Different Antigen Bead Assays in Renal Transplant Recipients.
Ouranos K; Panteli M; Petasis G; Papachristou M; Iosifidou AM; Iosifidou MA; Anastasiou A; Samali M; Stangou M; Theodorou I; Lioulios G; Fylaktou A
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137802
[TBL] [Abstract][Full Text] [Related]
2. Comparison Between Total IgG, C1q, and C3d Single Antigen Bead Assays in Detecting Class I Complement-Binding Anti-HLA Antibodies.
Moreno Gonzales MA; Mitema DG; Smith BH; Schinstock CA; Stegall MD; Wakefield LL; Henderson NA; DeGoey SR; Kreuter JD; Gandhi MJ
Transplant Proc; 2017 Nov; 49(9):2031-2035. PubMed ID: 29149956
[TBL] [Abstract][Full Text] [Related]
3. Getting on target: Development of the novel, prozone-resistant, dual antibody rapid test (DART) for the LABScreen single antigen bead (SAB) assay.
Greenshields A; Bray RA; Gebel HM; Liwski RS
Hum Immunol; 2019 Jul; 80(7):468-477. PubMed ID: 31040048
[TBL] [Abstract][Full Text] [Related]
4. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients.
Zeevi A; Lunz J; Feingold B; Shullo M; Bermudez C; Teuteberg J; Webber S
J Heart Lung Transplant; 2013 Jan; 32(1):98-105. PubMed ID: 23142561
[TBL] [Abstract][Full Text] [Related]
5. C3d Assay in Correlation With Single Antigen Bead Assay for Human Leukocyte Antigen Antibodies.
Ko SY; Lee W; Jung CW; Cho Y
Transplant Proc; 2018 Oct; 50(8):2354-2358. PubMed ID: 30316357
[TBL] [Abstract][Full Text] [Related]
6. The correlation of results of panel reactive antibody, identification, and single antigen beads in detection of anti-HLA antibodies: Istanbul Faculty of Medicine, tissue typing laboratory experience.
Ciftci HS; Oguz FS; Cinar CK; Izgi DK
Transpl Immunol; 2023 Oct; 80():101891. PubMed ID: 37433395
[TBL] [Abstract][Full Text] [Related]
7. Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-Specific HLA Antibodies and C4d⁺ Antibody-Mediated Rejection in Kidney Transplant Recipients.
Tatapudi VS; Kopchaliiska D; da Gente GJ; Buenaventura OF; Singh M; Laszik Z; Adey DB; Rajalingam R
Ann Transplant; 2021 Dec; 26():e934175. PubMed ID: 34848674
[TBL] [Abstract][Full Text] [Related]
8. Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies.
Taylor CJ; Kosmoliaptsis V; Martin J; Knighton G; Mallon D; Bradley JA; Peacock S
Transplantation; 2017 Jun; 101(6):1206-1214. PubMed ID: 27306532
[TBL] [Abstract][Full Text] [Related]
9. Epitope Analysis Aids in Transplant Decision Making by Determining the Clinical Relevance of Apparent Pre-Transplant Donor Specific Antibodies (DSA).
Pandey S; Harville TO
Ann Clin Lab Sci; 2019 Jan; 49(1):50-56. PubMed ID: 30814077
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the C1q-Binding Ability and the IgG1-4 Subclass Profile of Preformed Anti-HLA Antibodies by Solid-Phase Assays.
Navas A; Molina J; Agüera ML; Guler I; Jurado A; Rodríguez-Benot A; Alonso C; Solana R
Front Immunol; 2019; 10():1712. PubMed ID: 31428086
[TBL] [Abstract][Full Text] [Related]
11. Effects of different sensitization events on HLA alloimmunization in renal transplant cases; a retrospective observation in 1066 cases.
Pandey P; Pande A; Mandal S; Devra AK; Sinha VK; Bhatt AP; Mishra S
Transpl Immunol; 2022 Dec; 75():101680. PubMed ID: 35908630
[TBL] [Abstract][Full Text] [Related]
12. Comparison of HLA antibody identification methods for the selection of platelet products for HLA-mediated platelet refractory patients.
Pedini P; Hubert L; Baudey JB; Etienne JM; Basire A; Vey N; Chiaroni J; Chabrières C; Ladaique P; Picard C
HLA; 2024 Jan; 103(1):e15276. PubMed ID: 37947374
[TBL] [Abstract][Full Text] [Related]
13. A modeling approach for mean fluorescence intensity value harmonization and cutoff prediction for luminex single antigen bead assays of two different vendors.
Karahan GE; Haasnoot GW; Voogt-Bakker K; Claas FHJ; Roelen D; Heidt S
HLA; 2023 Nov; 102(5):557-569. PubMed ID: 37130801
[TBL] [Abstract][Full Text] [Related]
14. Significance of Luminex-based single antigen class II bead assay and its mean fluorescence intensity in renal transplant cases; a retrospective observation in 97 cases.
Pande A; Pandey P; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
J Immunoassay Immunochem; 2020 May; 41(3):322-336. PubMed ID: 32122239
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Complement-Binding Capacity of HLA Antibodies Based on Mean Fluorescence Intensity.
Zhao J; Fu YX; Yang T; Shen ZY; Wu CL
Transplant Proc; 2016; 48(6):2235-40. PubMed ID: 27569975
[TBL] [Abstract][Full Text] [Related]
16. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.
Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT
Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534
[TBL] [Abstract][Full Text] [Related]
17. From Accurate Assessment of Anti-HLA Antibody MFI to Complement-Binding Assays.
Claisse G; Mariat C; Maillard N
Clin Transpl; 2016; 32():153-160. PubMed ID: 28564533
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients.
Lee H; Han E; Choi AR; Ban TH; Chung BH; Yang CW; Choi YJ; Oh EJ
PLoS One; 2018; 13(11):e0207434. PubMed ID: 30427941
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different luminex single antigen bead kits for memory B cell-derived HLA antibody detection.
Karahan GE; de Vaal Y; Bakker K; Roelen D; Claas FHJ; Heidt S
HLA; 2021 Sep; 98(3):200-206. PubMed ID: 34216435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]